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1. INTRODUCTION 
 
1.1. Architecture of the lung  
 
The lung is a twin organ that is located in the chest, and is connected to the external 
environment by the trachea that divides into two principal bronchi. Further divisions 
generate the bronchi lobares, bronchi segmentales, bronchioli, bronchioli terminales, 
bronchioli respiratorii, ductus alveolares and alveoli. The alveoli are the locations for 
the gas exchange (99).  
The alveoli are built from two types of epithelial cells, the type I pneumocytes and type 
II pneumocytes. The type I pneumocytes are responsible for gas exchange between the 
air in the alveoli and the blood in the capillary of the pulmonary vascular tree (52, 99). 
The alveolar type I cells cover approximately 95% of the alveolar surface (52). Further, 
the type I cells are part of the blood-gas barrier that separates the alveolar airspace from 
the interstitium (99). The type II pneumocytes cover approximately 5% of the alveolar 
surface and produce and secrete surfactant (52, 99). Another function of these cells is to 
clear fluid from the alveolus to prevent pulmonary oedema (52). Type II pneumocytes 
can also transform into type I pneumocytes (52, 99). Further, it is known that type II 
pneumocytes participate in immunologic reactions by producing cytokines and growth 
factors (52).  
Another cell type involved in the generation of alveoli are interstitial pulmonary 
fibroblasts, which are responsible for the development and formation of the pulmonary 
extracellular matrix (ECM) (52). 
Additional cell types that can be found in the lung are chondrocytes that are involved in 
the construction of the bronchial wall, adenocytes, so-called Clara cells in the wall of 
the bronchioli terminales, endothelial cells in the vessels, red blood cells and cells of 
the immune system (99).  
 
 
1.2. Physiology of the lung  
 
The function of the lung is to exchange gases by diffusion. That means the absorption of 
oxygen from the air and transmission to the blood, and transmission of CO2 from the 
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blood to the alveoli with release of CO2 into the air. For this, it is necessary that the air 
in the lung is regularly exchanged because gas diffusion is dependent upon a 
concentration gradient. The exchange of gas between the lung and the environment 
occurs by breathing. The airflow adjusts to volume changes of the lung. 
The volume of the chest depends on the movement of the ribs and the diaphragm. The 
thoracic cavity is lined by the pleural sheets, where the pleura visceralis is linked to the 
lung and the pleura parietalis is linked to the ribs and the diaphragm. Because of a 
negative pressure between these sheets, thoracic expansion and contraction of the 
diaphragm lead to an increase in intrathoracic volume and an expansion of the lung with 
a negative pressure in the airways leading to a passive air flow into the lung. 
Decontraction of the diaphragm and descent of the ribs combined with the elastic 
retraction forces of the lung lead to a decrease in the volume of the thoracic cavity 
leading to air flow out of the lung. These dynamics can be illustrated with a pressure-
volume curve [Figure 1; (106)]. 
   
 
Figure 1: Pressure-volume curve in relaxed breathing. The intrapleural pressure - which translates 
to the intrathoracic cave - changes the intrapulmonary volume and the air flow. The intrapleural 
pressure is progressively negative from the left to the right. Modified from: (106). 
 
 
   
Components that affect the gas exchange, apart from the gas concentrations in the blood 
and the air in the alveoli, are the surface area that participates in gas exchange, and the 
thickness of the alveolar septal wall that has to be transcended by the gases (106).  
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1.3. Acute respiratory distress syndrome  
 
1.3.1. Pathophysiology 
 
Acute respiratory distress syndrome (ARDS) is defined as a severe lung injury with 
acute onset, significant hypoxaemia, bilateral infiltrates on frontal chest radiography, 
and the absence of left ventricular failure (10, 36). 
Hypoxaemia is measured by the PaO2/FIO2 ratio. That means the partial pressure of 
arterial oxygen related to the fraction of inspired oxygen. This ratio must be ≤300 for 
the diagnosis acute lung injury (ALI).  Acute respiratory distress syndrome is the most 
severe subset of ALI with a PaO2/FIO2 ratio ≤200 (10, 36).  
Symptoms of left ventricular failure can be dyspnoea, tachypnoea, cardiac asthma, basal 
rales, cyanosis, weakness, and cerebral dysfunction. The absence of left ventricular 
failure is equivalent to the absence of left atrial hypertension. The left atrial pressure can 
be assessed by the pulmonary capillary wedge pressure (PCWP). A PCWP of 
≤18mmHg represents a normal left atrial pressure (51).    
Lungs affected by acute respiratory distress syndrome exhibit morphologic and 
functional alterations in comparison with healthy lungs: the respiratory compliance is 
less, the dead space - parts of the lung that do not participate in gas exchange - is 
increased, and the partial pressure of arterial CO2 is elevated (39). 
The basis of ARDS is a direct or indirect pulmonary injury. Aspiration of gastric 
contents, pneumonia, inhalation of toxic gases, inhalation of hyperbaric O2, intoxication 
with local applied narcotic drugs or lung transplantation can lead to a direct injury. 
Reasons for an indirect injury can be a sepsis, shock, lipid embolism, burns, intoxication 
with systemic applied drugs, and pathologic intravascular coagulation (50). 
Irrespective of the aetiology, ARDS has three phases. The first is the exudative phase, 
the second the proliferative phase, and the third the fibrotic phase (35, 81, 109). The 
exudative phase takes up to six days and is characterised by hyaline membranes in the 
alveolar walls, oedema and inflammation (81, 109). The four to ten days of the 
proliferative phase are characterised by a metaplasia of pneumocytes with reduced 
production of surfactant and proliferation of myofibroblasts (35, 81). Lung fibrosis and 
pulmonary hypertension are the leading characteristics of the eight or more days that 
make up the fibrotic phase (81, 109).  
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The survival in ALI/ARDS depends on the age of the patient, accessory chronic 
diseases, and extra-pulmonary organ dysfunction (11).   
Acute respiratory distress syndrome and ALI are common diseases with a significant 
socio-economic burden. The accurate incidence rates differ depending on the criteria 
used to diagnose ALI and ARDS in different studies, and depending on the selected 
population. For example, Luhr et al. found with the criteria of the American-European 
Consensus Conference [see above, (10)] incidence rates of 13.5 cases per 100,000 
inhabitants per year for ARDS and 17.9 cases of ALI per 100,000 inhabitants per year 
for Sweden, Denmark and Iceland (62, 75). The 90 day mortality in this study was 
above 41% in ARDS and in ALI patients (75).  
 
 
1.3.2. Animal models 
 
Multiple animal models for ARDS exist. Pneumonia can be induced by intratracheal 
instillation of E. coli. Due to this infection, the inflammatory response in this model is 
higher than in non-infectious animal models (57). Another manner of inducing ARDS is 
the infusion of lipopolysaccharide (LPS) as a model for sepsis (58). In the LPS model, 
inflammation and haemorrhage play the crucial role in lung injury (58). By injection 
into the central venous vasculature, oleic acid arrives in the pulmonary vessels and leads 
to endothelial and epithelial necrosis in the lung (86). In this case, the lung develops 
oedema and atelectasis (57, 86). Another possibility to induce lung injury is the repeated 
lavage of the lung with saline, causing surfactant depletion (57, 58, 86). This model is 
applied as a model for neonatal respiratory distress syndrome and for early ALI in 
adults (57). Lachmann et al. developed the saline washout model for removing 
surfactant phospholipids from the alvoeli. This procedure causes collapse of unstable 
alveoli and subsequent conditions similar to ARDS (60). While the pneumonia model is 
chracterised by a gross inflammation, the oleic acid injection and saline lavage models 
induce lung injury by a reduction in respiratory system compliance and gas exchange 
(57). In both models the respiratory mechanics and the decreased gas exchange that lead 
to hypoxaemia are similar (73, 97). Beyond that, the oleic acid model is marked by a 
distinct oedema (86). Whereas two of these models (LPS, oleic acid) represent indirect 
lung injurious mechanisms, the pneumonia and the saline lavage models lead to a direct 
lung injury. The saline lavage model produces acute hypoxaemia where the animal is 
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haemodynamically stable (97). It is conceivable that the inflammatory response in the 
pneumonia model leads to a haemodynamic instability in terms of cardiovascular 
decompensation.    
 
 
1.4. Ventilator-induced lung injury  
 
1.4.1. Pathophysiology 
 
Physiologically, breathing works because air flows into the lung due to a negative intra-
thoracic pressure. Mechanical ventilation changes the mechanism by which air enters 
the lung. 
Ventilator-induced lung injury (VILI) results from injurious mechanical ventilation. 
Mechanical ventilation is a method for oxygenation of patients who are not able to 
breathe by themselves or who are in danger of being unable to breathe by themselves. 
Therapeutic mechanical ventilation is used for central respiratory paralysis (e.g. during 
depression of the respiratory centre in the brainstem by drugs such as barbiturates or 
opioids; or because of damage to the respiratory centre by a trauma or a tumour), for 
peripheral respiratory paralysis (e.g. due to paraplegia or a muscle relaxant), for lung 
failure (e.g. because of oedema, pneumonia or pulmonary embolism), for disordered 
respiratory mechanics (e.g. by fractures of serial ribs or fracture of the sternum) and for 
an increase in respiratory resistance. Prophylactic mechanical ventilation is used on 
unconscious patients for preventing aspiration, on patients who have already aspirated, 
on patients with an extended shock, on patients with a sepsis, on patients with burns, for 
elevated intracranial pressure and for attenuating cardio-pulmonary stress (103). 
Ventilator-induced lung injury includes barotrauma, volutrauma, atelectrauma, and 
biotrauma (43, 102). Barotrauma is associated with very high positive end-expiratory 
pressure (PEEP) of >40 cm H2O and with peak inspiratory pressures (PIP) of >100 cm 
H2O; but barotrauma does not seem to play an essential role in VILI (54, 102).  
As Halbertsma et al. describe, the main determinant of volutrauma is the end-
inspiratory volume (43). Volutrauma consists of diffuse alveolar damage, pulmonary 
oedema, an increase in fluid filtration, and loss of epithelium barrier (102). Dysfunction 
or inactivation of surfactant during mechanical ventilation may also participate in the 
development of oedema through a change in epithelial permeability due to an increase 
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of alveolar surface tension (34). Another reason for oedema appears to be the disruption 
of the blood-gas barrier, primarily in the endothelium due to loss of the endothelial cell 
contact to the basement membrane during injurious ventilation (118).  
Cyclic opening and collapse of the alveoli during mechanical ventilation causes an 
increase in working stretch and shear forces resulting in lung injury [atelectrauma; (43, 
102)]. Dreyfuss and Saumon speculate that at the beginning of the atelectrauma, 
surfactant inactivation leads to atelectasis with an augmentation of shear stress (34).  
The fourth component of VILI - biotrauma - is due to an upregulation of cytokine 
production in the lung, causing an inflammation - mainly an immigration of neutrophils 
into the alveolar spaces (53) ˗ and further injuring of the lung. Mechanical ventilation 
may lead to systemic inflammatory response syndrome (SIRS) and to multiple-system 
organ failure (MSOF), leading to death (33, 102).  
 
 
Figure 2:  Effect of mechanical ventilation on a pressure-volume curve. The boxes mark the most 
susceptible ventilation conditions for the development of the designated components of VILI. The 
pressure increases from the left to the right. Modified from: (102).         
 
 
Figure 2 illustrates regions in the pressure-volume curve that are associated with 
different components of VILI (102). The International Consensus Conference in 
Intensive Care Medicine identified volutrauma and atelectrauma as the two main 
determinants of VILI (54). The menace of atelectrauma is greatest during ventilation 
with pressures below the lower inflection point (96). The lower inflection point is 
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thought to represent the pressure/volume at which the alveoli are recruited (122). The 
risk of volutrauma is greatest using pressures above the upper inflection point (96). This 
upper inflection point marks the pressure/volume at which the alveoli are damaged due 
to overinflation (122). 
The two most important cell types for the development of VILI seem to be alveolar 
macrophages and the pneumocytes (33). It has been shown that macrophages are 
responsible for an intense increase of interleukin (IL)-8 production due to mechanical 
stress (38). Macrophages also seem to play a crucial role in the mechanical stress-
induced lung remodelling. Furthermore, high TNFα (tumour necrosis factor α) 
production seems to be dependent on macrophages (33). Another source of chemokines 
may be the alveolar epithelial cells that produce TNFα in response to injurious 
ventilation. Dos Santos and Slutsky postulate a crucial role for the pneumocytes as 
cytokine and chemokine producers in VILI because of the highly exposed position of 
the pneumocytes with respect to the mechanical stimuli during mechanical ventilation 
(33).  
 
 
Figure 3: Overview of potential mechanisms of development and consequences of VILI. Modified 
from: (38).   
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It is hypothesised that there are reciprocal interactions between the biotrauma-related 
immunoreactions and mechanical stress leading to volutrauma, because microbial 
products such as LPS enhance responses due to mechanical ventilation, and mechanical 
stress aggravates this response to microbial products (78). Figure 3 provides an 
overview of potential mechanisms involved in VILI (38).  
 
 
 
1.4.2. Lung protective ventilation 
 
One lung protective ventilation management strategy (90) is known as the “open lung” 
concept that was coined by Lachmann. The components of this strategy are a pressure-
controlled ventilation with an initial PIP of 40 – 60 cmH2O (recruitment maneuver) that 
is adjusted individually due to recruitment, a ratio of the duration of inspiration to 
expiration (I:E) of 1:1 to 2:1, a PEEP of 10 – 20 cmH2O, a permissive hypercapnia, and 
an initial inspired O2 concentration of 100% that is reduced in long term ventilation to 
levels as less as tolerated by the patient. The fundamental idea is that terminal units are 
stabilised with an appropriate level of PEEP. This leads to an increase in the aerated 
lung fraction and may reduce regional overinflation so that VILI could be limited (54, 
74). Further, PEEP may lessen the atelectrauma by stabilising the terminal units leading 
to less shear stress of the pneumocytes (34, 38, 90). This could be explained by 
preserved surfactant function (38). Using PEEP also decreases extravascular lung water 
(74). Setting the PEEP over the lower inflection point results in an increase in the 
arterial oxygenation, suggesting a better gas exchange with this strategy compared with 
inadequate PEEP (96, 104). 
The ARDS Network established the benefit of a low tidal volume ventilation strategy 
(105). It was found that the mortality was less in that group compared with a group 
ventilated with higher tidal volumes. The ventilation-free days and the days without 
nonpulmonary failure were more numerous than in the control group. A decrease in 
mortality was also observed in ventilation treatments using low tidal volumes and low 
inflation pressures (54) suggesting that a combined ventilation strategy consisting of 
low tidal volume and higher PEEP could lead to an increase in the survival rate in 
patients requiring mechanical ventilation (4, 38, 54). This strategy also seems to 
attenuate the biotrauma (54, 90). Tremblay et al. demonstrated that ventilation with high 
PEEP and a moderate tidal volume damps the increase in cytokine levels [TNFα, IL-1β, 
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IL-6, interferon γ (IFNγ), IL-10] in the bronchoalveolar lavage (BAL) fluid compared 
with ventilation strategies without PEEP in isolated rat lungs (110). The findings for the 
IL-6 values were confirmed for human patients by the ARDS Network (105). 
In rat models of VILI, pulmonary oedema was less severe using 30 cmH2O PIP instead 
of 45 cmH2O PIP indicating a less severe process of the VILI. There is evidence that 
ventilation strategies for reaching a defined target end-inspiratory pressure cause milder 
oedema and less lung injury if these strategies include PEEP combined with a lower 
tidal volume (96). It has been shown that high PEEP ventilation leads to less alveolar 
damage by preventing alveolar instability (91). One study suggests that PEEP and low 
tidal volume ventilation have synergistic effects in stabilising the alveoli in which 
increasing PEEP has a greater effect than reducing the tidal volume (44).  
There is evidence that a further improvement in survival could be achieved by 
additional application of recruitment maneuvers. These maneuvers may consist of a 40-
second breathhold at 40 cmH2O airway pressure (79). Other studies suggest that higher 
PEEP levels (above the lower inflection point) lead to a higher weaning rate from 
mechanical ventilation (5) and a homogenous low tidal volume ventilation (9) whereas 
there is no improved survival in ventilation strategies with high PEEP in comparison to 
lower PEEP (14).  
The American-European Consensus Committee on ARDS postulated the following 
goals for “adequate” mechanical ventilation: 1) ensuring of an appropriate gas 
exchange, 2) minimising O2 toxicity, 3) recruitment of the alveoli, 4) minimising the 
airway pressures, 5) prevention of atelectasis, and 6) responsible use of sedation (6). 
The state-of-the-art in mechanical ventilation treatment is the ARDS Network protocol 
consisting of low tidal volumes, titration of respiratory rate monitored by a target pH 
value of 7.3 to 7.45, and a combination of inspired O2 and PEEP leading to an oximetric 
saturation of 88 to 95% (40, 105). A modest hypercapnia due to low tidal volumes is 
permitted because it is tolerated in most patients (5, 40). 
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1.5. Intracellular mechanisms of converting mechanical stimuli 
 
1.5.1. Responses to mechanical forces 
 
Mechanical forces influence a multitude of cellular functions, including changes in cell 
shape, growth, differentiation, cell-cycle kinetics, apoptosis, motility, gene expression, 
and remodelling of the ECM (20). These mechanisms have to be seen as adaptational 
mechanisms to extracellular forces via intracellular signalling processes. If the 
mechanical stimuli are too strong, the cell membrane is destroyed. Due to this 
destruction the cellular adaptation becomes impossible (114). 
 
 
1.5.1.1. Cell death 
 
There are two forms of cell death. One of these is necrosis. Necrosis is a form of cell 
death due to cell swelling and uncontrolled disruption of the cell membrane leading to 
liberation of the cell contents. This, in turn, causes inflammatory responses in the direct 
environment of the concerned cells (47, 77).  This form of cell death is thought to play a 
role in epithelial cell death due to alveolar overdistension (77). There is evidence that 
type II pneumocytes become necrotic due to increased mechanical stretch in vitro (46). 
In contrast, apoptosis is characterised by the formation of membrane bodies, nuclear 
pyknosis due to condensation of the chromatin, and nuclear fragmentation. Furthermore, 
there is no inflammatory response in the environment of the cells because the cell 
contents are not liberated in a free form but in membrane bodies that can be ingested by 
phagocytic cells. This form of cell death is also known as controlled cell death (47).  
 
 
1.5.1.2. Pro-apoptotic pathways 
 
Apoptosis can be promoted by caspases which can be activated by released 
mitochondrial products as cytochrome c or the so-called death receptors. To the death 
receptors belong TNF receptors and the Fas receptor (77), which can be activated by 
TNFα or Fas ligand (47, 77). The Fas ligand exists in two forms, a soluble form and a 
membrane related form on the surface of cytotoxic lymphocytes (77). There are several 
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different targets of the caspases such as PARP [poly-adenosine diphosphate (ADP)-
ribose polymerase] that are cleaved by these proteases (71). Cleavage of the targets 
leads to deoxyribonucleic acid (DNA) fragmentation, nuclear membrane disruption, 
chromatin condensation, and collapse of the cytoskeleton (71). The Fas/Fas ligand 
system is known to be more activated in ARDS (3, 49, 56), where the complex 
promotes apoptosis (3). Kitamura et al. demonstrated a Fas/Fas ligand-dependent 
mechanism of apoptosis in alveolar epithelial and endothelial cells for murine LPS-
induced ALI model (56). That apoptotic mechanisms play a role in the development of 
ARDS is supported by the observations of Hashimoto et al. who found increased levels 
of the Fas molecule in the BAL fluid of ARDS patients (49). These findings suggest a 
destruction of the alveolar barrier leading to severe alveolar oedema and due to this a 
poor outcome of the patients. In the lung tissue of patients who died with ALI/ARDS, 
markers of apoptosis such as caspase-3, Bax, and p53 were found (3). In vitro studies 
demonstrated that type II pneumocytes undergo apoptosis in response to mechanical 
stress (46).    
Another protein involved in apoptosis is p53. This protein is able to promote apoptosis 
in a transcription-dependent manner by recruitment of transcription factors (p53-
inducible genes) and in a transcription-independent manner by cytochrome c release and 
caspase activation (93). One direct transcriptional target for p53 is the gene of the 
apoptotic peptidase activating factor 1 (Apaf1) (37). Apaf1 binds pro-caspase 9 and 
activates this caspase which itself activates caspase 3 (29, 64). Caspase 3, in turn, 
cleaves different cell proteins such as PARP or retinoblastoma proteins leading to 
apoptosis (64). Another target of p53 is the p21 encoding gene CDKN1A (cyclin-
dependent kinase inhibitor 1a), which regulates several different cellular functions. 
Generally, p53 leads, via CDKN1A expression, to cell cycle arrest, not to apoptosis (7, 
27, 28). Further findings underscore an anti-apoptotic role of CDKN1A, since Lu et al. 
demonstrated the induction of CDKN1A by activating the phosphoinositide 3-kinase 
(PI3K)/Akt pathway leading to cell protection from p53-induced apoptosis in prostate 
cancer (72). There is also evidence that p21 expression is dependent upon Akt 
phosphorylation in ovarian carcinoma cell lines and endothelial cells (82, 100). In 
human urothelial carcinoma cells, activation of the PI3K-Akt pathway leads, via 
suppression of GSK3β (glycogen synthase kinase 3β) and activation of mTOR 
(mammalian target of rapamycin), to CDKN1A induction (124).  
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A further target of p53 is the growth arrest and DNA damage gene 45a (GADD45A). 
GADD45A can also be induced in a p53-independent manner, which leads usually to 
cell cycle arrest and induction of DNA repair (7, 88). Whether Gadd45 is involved in 
pro- or anti-apoptotic mechanisms depends on the interaction partner recruited. In 
cooperation with p53, Gadd45 is pro-apoptotic (66). Gadd45a is able to act in an anti-
apoptotic fashion by interaction with β-catenin or Akt (80, 111). In a pneumonia ARDS 
model, it was shown that Gadd45a-deficient mice sustain a higher vascular barrier 
dysfunction than others because of an inadequate degradation of Akt (80). 
An overproduction of reactive oxygen species (ROS) is known to induce both apoptosis 
and necrosis (47). Reactive oxygen species can be increased in VILI due to mechanical 
stress (1, 19).  
Mitogen-activated protein kinases play also an important role in conversion of pro-
apoptotic stimuli, in particular p38 and JNK (see section 1.5.1.4). An overview of some 
pro-apoptotic pathways is provided in Figure 4.  
 
 
Figure 4: Overview of some pro-apoptotic mechanisms. CytoC: cytochrome c, FasL: Fas-ligand, 
FasLR: Fas-ligand receptor, ROS: reactive oxygen species, XOR: xanthine oxido-reductase. 
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1.5.1.3. Anti-apoptotic pathways 
 
Stretch can activate phospholipase c (PLC)-γ directly, or stretch activates protein 
tyrosine kinases (PTK) that activate, in turn, PLC-γ. The activated PLC-γ divides 
phosphatidylinositol-4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol-
1,4,5-trisphosphate (IP3). This leads to an increase of Ca2+ influx into the cell and 
activation of the protein kinase c (PKC). It is known that this pathway is involved in 
proliferation of foetal rat lung cells in response to cyclic stretch and strain (70, 123). 
Phosphoinositide 3-kinase is also able to cleave PIP2 into DAG and IP3 (65). This 
kinase is activated during high PIP ventilation due to an increase in intracellular Ca2+ 
concentration by a Ca2+ entry through stretch activated ion channels (83). Other 
possibilities of PI3K activation are the activation by hepatocyte growth factor (HGF) 
(45, 69), keratinocyte growth factor (KGF) (8, 45), IL-1β (80), bradykinin (45) and 
transforming growth factor (TGF)-β (23) as well as platelet-derived growth factor 
(PDGF) (108). It can also be activated by ROS (2).  
Phosphoinositide 3-kinase phosphorylates different downstream target proteins. One of 
these targets is Akt. Akt phosphorylates GSK3β that is inactivated in a phosphorylated 
state (69, 83, 108). Dephosphorylated GSK3β is involved in neutrophil infiltration into 
the lung, in apoptosis, in TNF-α and IL-1β production, and in lung injury (26). Further, 
active GSK3β initiates the degradation of β-catenin by phosphorylation. It is known that 
β-catenin plays a crucial role in the integrity of adherens junctions and for the 
maintenance of the blood-gas barrier in the lung. Phosphorylation of β-catenin leads to 
reduced epithelial and endothelial barrier properties. Taken together, Akt prevents 
blood-gas barrier dysfunction following the development of oedema (69, 83). 
An important function of Akt is the inhibition of apoptosis (45, 83, 108). Different 
aspects of the anti-apoptotic effects of Akt have been discussed. Akt seems to preserve 
the mitochondrial membrane by preventing cytochrome c release. Further, Akt is known 
to inhibit pro-apoptotic proteins in a direct and an indirect manner. Finally, Akt 
modulates gene transcription by phosphorylation of different transcription factors, such 
as forkhead or nuclear factor-κB (NF-κB) (125). The Akt deactivation is associated with 
cell death in several cell systems. One study suggests a dependence of the activation 
status of Akt on nitric oxide and Ca2+ (76) suggesting a pro-apoptotic effect of 
gadolinium-sensitive Ca2+ channels (119) and of eNOS (endothelial nitric oxide 
synthase) (21) leading to vascular barrier dysfunction in response to mechanical stress 
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in VILI. Prevention of stretch-induced apoptosis in type II pneumocytes seems to be 
possible by activating the PI3K-Akt pathway (45).  
There is evidence that the PI3K-Akt pathway leads to an enhanced expression of FGF2 
(fibroblast growth factor 2) (17, 113, 127). Fibroblast growth factor 2 is known to play a 
crucial role in cell survival via the PI3K-Akt pathway due to binding the FGF receptor 
inter alia in epithelial cells (120). Thus, it is conceivable that a mechanism exists of 
autocrine/paracrine self-induction of FGF2 expression via Akt leading to cell survive as 
described for malignant carcinoma cells (12). Another factor that is influenced by Akt-
mediated gene expression is HGF (113) that regulates gene expression via Akt (61). 
Gnecchi et al. postulate a paracrine upregulation of HGF (and FGF2) via Akt leading to 
cytoprotection in cardiomyocytes (41). An augmentation of HGF in ALI (24) is 
described as well as a crucial role of HGF in self-repair and anti-apoptotic mechanisms 
in lung cells (85).  
A further function of the PI3K-Akt pathway is the regulation of cell proliferation (94). 
By stimulation of glucose metabolism, Akt increases intracellular ATP (adenosine 
triphosphate) levels. Low ATP levels are a sign of poor energy status of the cell, and 
can lead to controlled cell death (42). Adenosine monophosphate (AMP)-activated 
protein kinase (AMPK) is a kinase that acts as an energy status sensor that is activated 
by an increase in the intracellular AMP:ATP ratio, signalling a low energy state of the 
cell (48, 84). Activation of AMPK can lead to cell cycle arrest or apoptosis via p53 (48, 
84, 93). Another target of AMPK is mTOR, a factor involved in protein synthesis and 
cell growth. AMPK is able to inhibit mTOR (48, 84). Taken together, Akt is able to 
inhibit AMPK activation indirectly by increased production of ATP. 
Akt has also been shown to play a role in the neutrophil activation in ALI (125). Li et 
al. presented data that suggest that high tidal volume ventilation combined with 
hyperoxia leads, via Akt, to an augmentation of eNOS expression leading to lung 
neutrophil infiltration (63).  
Another target of PI3K is Src, a protein that promotes β-catenin degradation. Src leads 
to an increase in vascular permeability. The fact that there is gross oedema in high PIP 
ventilated mice is explained by Miyahara et al. in the way that there is an imbalance 
between the PI3K modulated downstream effects in favour of the Src pathway (83). 
Mitogen-activated protein (MAP) kinases may be involved in anti-apoptotic pathways 
as well (see section 1.5.1.4). An overview of some anti-apoptotic pathways is provided 
in Figure 5. 
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Figure 5: Overview of anti-apoptotic mechanisms via Akt. CytoC: cytochrome c, FGFR: fibroblast 
growth factor receptor, P: phosphate. The interrupted lines indicate the consequences of Akt 
activation. 
 
 
1.5.1.4. Mitogen-activated protein kinase pathways 
 
There are four known mammalian MAP kinases that are phosphorylated (and thus 
activated) by different MAP kinase kinases. The mitogen-activated protein/extracellular 
signal-related kinase kinases (MEK) 1 and 2 activate extracellular signal-related kinases 
(ERK) 1 and 2, the mitogen-activated protein kinase kinases (MKK) 3 and 6 activate 
p38, MKK4/7 activate c-Jun amino-terminal kinase (JNK), and MEK5 activates ERK5 
(18, 25).    
Uhlig et al. demonstrated that the MAP kinases JNK and ERK1/2 are more 
phosphorylated in rats ventilated with high pressure compared with normally ventilated 
rats, but saw no differences in p38 phosphorylation (115). The ERK activation due to 
mechanical stress was confirmed for rat pneumocytes (22). In contrast, it was also 
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observed activation of p38 and ERK 1 and 2 in high tidal volume ventilated mice, but 
no difference in the activation state of JNK was noted (1). MAP kinases are known to 
transduce extracellular stimuli to the nucleus where they modify gene expression (18, 
115). Further, MAP kinases can modulate gene expression via post-transcriptional 
modification of messenger ribonucleic acid [mRNA; (18)]. 
The ERK activation can be explained by ligand binding to the epidermal growth factor 
receptor (EGFR) (112, 121). The EGFR has been shown to be up-regulated due to 
stretch (31). There is evidence that the EGFR is necessary for mechanotransduction in 
alveolar epithelial cells independent of ligand binding (22). Other mitogens that are able 
to activate the ERK cascade are KGF (94), PDGF, TGF-β (121) and insulin (25). 
Activation of these receptors leads to activation of the MAPK pathway via the G-
protein Ras (25, 30, 117), whereas the mechanotransduction seems to be independent of 
Ras (22). Further, there is evidence that lung epithelial cells may activate ERK cascades 
via Fas/Fas ligand interactions in vitro (92). Finally, the ERKs as well as p38 and JNK 
can be phosphorylated in response to KGF binding to a receptor on type II pneumocytes 
leading to proliferation and differentiation (95). ERKs are known to be involved in 
cytokine production (25, 89, 92), cell proliferation (94) and prevention of apoptosis due 
to hyperoxia (15) as well as in activation of the xanthine oxidoreductase (XOR), an 
enzyme that can generate ROS, due to mechanical stress (1). 
The p38 kinase is also known to play a role in the XOR activation. XOR activation is 
discussed to play an important role in loss of the blood-gas barrier function in VILI (1). 
Reactive oxygen species are increased generated in VILI leading to oxidant stress and a 
following increase of production of IL-1β, IL-6, and TNFα (19). The ROS are also 
known to play an important role in murine lung epithelial cell death due to hyperoxia 
(1). The kinase p38 by itself is also very important for the gene expression of TNF, IL-
1, IL-6, and IL-8 (25, 89). Further, p38 can phosphorylate the GSK3β (69, 107). Finally, 
there is evidence that p38 may be involved in TGF-β1-induced blood-gas barrier 
dysfunction (13). 
Ning and Wang postulate a key role for ERK1/2 and p38 in cellular response to 
mechanical ventilation (87). It was observed an activation of these MAP kinases via 
PKC leading to transcription of pro-inflammatory chemokines encoding genes due to 
activation of NF-κB (87). It has been shown that activation of ERK1/2 due to MEK1/2 
activation may lead to an increased degradation and inactivation of the transcription-
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related peroxisome proliferator-activated receptor PPARγ. Due to this inactivation the 
ERK1/2 may be responsible for lung injury in sepsis (55). 
Extracellular signal-related kinases 1 and 2 are considered to be important for cell 
survival, whereas JNK and p38 may induce apoptosis via Fas ligand induction (18). A 
reduction of apoptosis in p38- and JNK-deficient mice under moderate tidal volume 
ventilation has been demonstrated, as well as a decrease in oedema levels in JNK-
deficient mice, suggesting an important role for p38 and JNK in development of VILI 
(32). Further, there is evidence that p38 activation by TGF-β1 is involved in pro-
apoptotic mechanisms in lung epithelial cells (116). Taken together, there are findings 
suggesting both pro-survival and cell death roles for ERK1/2. The JNK and p38 are 
involved in cell death mechanisms. 
 
 
1.6. Aim of the study 
 
The hypothesis of this study was that intracellular signalling pathways in pneumocytes 
protect cells from damage in an “open lung” ventilation strategy compared to low 
PEEP and high PIP ventilated lungs. 
The goal of this study was to identify molecular mechanisms that could be involved in 
the protection of the lung tissue during the lung protective ventilation strategy using 
high PEEP and low tidal volumes in contrast to a ventilation strategy using lower PEEP 
in a saline washout ARDS rat model. This would be determined as follows: 
1)  Nucleic acids and proteins would be extracted from the lung tissues. 
2)  The activation of cell protective and cell death pathways would be examined. 
3)  Areas of cell death in ventilated lungs would be examined to identify the 
 affected cell type. 
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2. MATERIALS AND METHODS 
 
2.1. Materials 
 
2.1.1. Equipment 
 
Block heater HBT 130 HLC, Germany 
Cannula 22G BD, Netherlands 
Centrifuge Biofuge fresco Kendro Laboratory Products, USA 
Developing machine; X Omat 2000 Kodak, USA 
Falcon tubes: 15 ml, 50 ml Greiner Bio-One, Germany 
Film cassette Sigma-Aldrich, Germany 
Filter Tip FT: 10, 20, 100, 200, 1000 Greiner Bio-One, Germany 
Fluorescence microscope; Leica AS MDW Leica, Germany 
Freezer -80 °C Heraeus, Germany 
Fridge +4 °C Bosch, Germany 
Fusion A153601 Reader Packard Bioscience, Germany 
Glass bottles: 250 ml, 500 ml, 1000 ml Fischer, Germany 
GS-800™ Calibrated Densitometer Bio-Rad, USA 
Hyperfilm™ ECL High Performance  Amersham Biosciences, UK 
Mini spin centrifuge Eppendorf, Germany 
Microtom Micron cool-cut HM355S Micron, Germany 
Mortar Haldenwanger, Germany 
Multipette® plus Eppendorf, Germany 
Nanodrop® spectrophotometer Peqlab, Germany 
Nebuliser Penn-Century, USA 
Needle 20G Becton Dickinson S.A., Spain 
PAP pen Sigma-Aldrich, Germany 
PCR thermocycler MJ Research, USA 
Pestle Haldenwanger, Germany 
Pipetman: P10, P20, P100, P200, P1000 Gilson, France 
Pipette tip: 200 µl, 1000 µl Sarstedt, Germany 
Pipette tip: 10 µl, 20 µl, 100 µl Gilson, USA 
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Platform shaker Titramax 1000 Heidolph, Germany 
Power supply; PowerPac 300 Bio-Rad, USA 
Roto-Shake Genie Scientific Industries, USA 
Scalpel FEATHER, Japan 
Scientific Imaging Film X-OMAT™ LS Kodak, USA 
Test tubes: 0.8 ml, 1.5 ml, 2.0 ml Greiner Bio-One, Germany 
Test Tube Shaker Merck Eurolab, Germany 
Thermo-Fast® 96 PCR plate Thermo Scientific, USA 
Trans-Blot® Transfer Medium Bio-Rad Laboratories, USA 
Ventilator Servo 300 Siemens Elema, Sweden 
Western blot chambers: Mini Trans-Blot Bio-Rad, USA 
 
2.1.2. Reagents 
 
Acrylamide solution, Rotiphorese Gel 30 Roth, Germany 
Alexa Fluor 488 goat anti-mouse IgG Invitrogen, USA 
Alexa Fluor 555 goat anti-rabbit IgG Invitrogen, USA 
Ammonium persulfate Promega, USA 
Bovine serum albumin Sigma-Aldrich, Germany 
Bromophenol blue  Sigma-Aldrich, Germany 
Complete ™Protease Inhibitor Roche, Germany 
4ʹ,6-Diamidino-2-phenyl-indol-dihydrochloride Sigma-Aldrich, Germany 
DEPC water Roth, Germany 
Dithiothreitol Promega, USA 
Dulbecco’s phosphate buffered saline 10× PAA Laboratories, Austria 
ECL Plus Western Blotting Detection Reagents Amersham Biosciences, UK 
Ethylenediaminetetraacetic acid Promega, USA 
Ethylene glycol-tetraacetic acid Sigma-Aldrich, Germany 
Glycerol  Merck, Germany 
β-glycerophosphate Sigma-Aldrich, Germany 
Glycine Roth, Germany 
Hydrochloric acid Sigma-Aldrich, Germany 
Isoflurane Pharmachemie, Netherlands 
β-mercaptoethanol Sigma-Aldrich, Germany 
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Methanol Fluka, Germany 
N,N,Nʹ,Nʹ-tetramethy-ethane-1,2-diamine Bio-Rad Laboratories, USA 
Nonfat dry milk Nestlé, Switzerland 
Pancuronium bromide NV Organon, Netherlands 
Pentobarbital Ceva Sante Animale, Netherlands 
Platinum® SYBR® Green qPCR SuperMix- 
UDG kit Invitrogen, USA 
Precision Plus Protein™ Standards Bio-Rad Laboratories, USA 
QuickStart™ Bradford Protein Assay Bio-Rad Laboratories, USA 
RNeasy Protect Mini Kit Qiagen, Germany 
Sodium citrate Merck, Germany 
Sodium dodecyl sulfate Promega, USA 
Sodium ortho vanadate Sigma-Aldrich, Germany 
Sodium pyrophosphate Sigma-Aldrich, Germany 
SuperScript™III First-Strand Synthesis System Invitrogen, USA 
Super Signal® West Pico Luminol/Enhancer  
Solution Pierce Biotechnology, USA 
Super Signal® West Pico Stable Peroxide  
Solution Pierce Biotechnology, USA 
Tris Roth, Germany 
Tris-Cl United States Biochemical, USA 
Triton X-100 Promega, USA 
Tween 20 Sigma-Aldrich, Germany 
VECTASHIELD mounting medium Vector Laboratories, USA 
 
 
2.2. Methods 
 
2.2.1. Animal models 
 
All procedures were approved by the experimental animal committee of the Erasmus 
Medical Center (Rotterdam, Netherlands). All animals were handled in strict accordance 
with the European Community Guidelines. Tissue samples were obtained from specific 
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pathogen-free male Sprague Dawley rats of 300 g (298 - 331 g, Harlan, Horst, 
Netherlands). 
The animals were anaesthetised after orotracheal intubation under gaseous anaesthesia 
(60% oxygen, 3% isoflurane), using a miniature nebuliser. A sterile polyethylene 
catheter was inserted into the carotid artery. Arterial blood gases and the blood pressure 
were monitored with this catheter. Thereafter, anaesthesia was changed into 
intraperitoneal pentobarbital sodium injections (60 mg/kg). Pancuronium bromide (2 
mg/kg, intramuscular) was used to induce muscle relaxation. Lungs were ventilated 
using a Servo Ventilator 300 as described in Table 1.  
 
Table 1: Ventilation settings of the different rat groups 
 low PEEP (1-6) high PEEP (7-12)  control (13-18) 
PIP [cmH2O] 28 30 14 
PEEP [cmH2O] 8 18 4 
I:E 1:2 1:1 1:2 
Frequency [min-1] 30 50-60 30 
Oxygen 100% 100% 100% 
FiO2 1.0 1.0 1.0 
PIP: peak inspiratory pressure, PEEP: positive end-expiratory pressure, I:E: inspiration: 
expiration, FiO2: fraction of inspired O2 
 
 
The rats were divided into three groups: six rats (numbers 1-6) were ventilated with a 
low PEEP ventilation setting after inducing lung injury, six rats (numbers 7-12) were 
ventilated with a high PEEP after inducing lung injury, and six rats (numbers 13-18) 
were ventilated without inducing lung injury as a control. For inducing lung injury, 
bronchoalveolar lavage with 1 ml/30 g body weight of isotonic saline solution (body 
temperature) was performed 6×.  
For every rat PaO2 and PaCO2 was measured before and after lavage and 60 and 120 
min after lavage. 
After the rats were sacrificed by infusion of an overdose of pentobarbital sodium, the 
thorax was opened and the lungs collected under sterile conditions. Immediately, BAL 
fluid was obtained by rinsing the airways three times with saline. The BAL fluid was 
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centrifuged (300 × g for 19 min at 4 °C), and the supernatant and lung tissue were 
stored at -80 °C. 
All these treatments of the rats were performed by a group from the Erasmus University 
in Rotterdam. 
Preparations of the whole organs were defrosted from -80 °C. Organs were placed in a 
mortar where the lungs were separated from bronchi using disposable scalpels. Lungs 
were placed in centrifuge tubes such that one lung of each rat could be used for protein 
and RNA investigations and one lung for histology analyses.  
 
 
2.2.2. Protein isolation from lungs 
 
Frozen lung tissue was crushed into powder under liquid nitrogen with a mortar and 
pestle. The powder was completely covered with lysis buffer (Table 2) for extracting 
proteins from tissue. The pH of the Tris was adjusted with hydrochloric acid. The 
phosphatase inhibitor sodium vanadate and the protease inhibitor cocktail were added 
immediately prior to use. The lysate was passed 5-8 × through a syringe needle (20 G) 
to fragment larger clusters of tissue. The lysate was placed in a centrifuge tube (2.0 ml) 
which was placed on ice for 30 min. Every 5 min, the sample was vortexed. The lysate 
was centrifuged at 4 °C at 13,000 rpm for 15 min. The supernatant was aliquoted into 
0.8 ml centrifuge tubes and frozen at -80 °C for further experiments. 
 
Table 2: Composition of the lysis buffer 
INGREDIENTS CONCENTRATION 
Tris (pH 7.5) 20 mM 
sodium chloride 150 mM 
EDTA 1 mM 
EGTA 1 mM 
Triton X-100 1 % 
Sodium pyrophosphate 2.5 mM 
β-glycerolphosphate 1 mM 
sodium vanadate 10 µl/ml 
CompleteTM Protease Inhibitor 40 µl/ml 
EDTA: ethylenediaminetetraacetic acid, EGTA: ethylene glycol tetraacetic acid 
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2.2.3. Determination of protein concentration 
 
After thawing, the protein concentration in the lysate was determined colometrically 
using a Bradford Protein Assay. Quick Start™ Bradford Dye Reagent (200 µl) was 
mixed with 20 µl of a 1:100 protein dilution. After an incubation of 15 min at room 
temperature the absorbance was measured at a wavelength of 570 nm with the Packard 
Fusion™ instrument. The protein concentration was calculated using the standard curve 
using Microsoft Excel. 
 
 
2.2.4. SDS polyacrylamide gel electrophoresis 
 
Proteins were separated using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). The SDS denatures proteins, binds to the polypeptides, 
and provides a consistent negative charge to the polypeptides allowing a migration of 
the proteins to the positive electrode in an electric field. The mobility of the proteins 
correlates negative with the protein size: larger proteins migrate slower than smaller 
ones. According to the molecular weight, the proteins can be separated. 
With 2× SDS loading buffer (Table 3) were combined 150 µg of protein. This mixture 
was heated at 95 °C for 10 min in a water bath before it was loaded onto the gel 
consisting of resolving gel (Table 4) and stacking gel (Table 5). Electrophoresis was 
carried out in running buffer (Table 6) at 90 V until the front dye reached the bottom of 
the gel.  
 
Table 3: Composition of the loading buffer 
INGREDIENTS CONCENTRATION 
Tris, pH 6.8 100 mM 
SDS  4% 
Bromophenol blue 0.2% 
Glycerol 20% 
DTT 200 mM 
SDS: sodium dodecyl sulfate, DTT: dithiothreitol 
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Table 4: Composition of the resolving gel  
INGREDIENTS AMOUNT FOR 1 GEL 
Distilled water 4 ml 
30% acrylamide 3.3 ml 
1.5 M Tris, pH 8.8 2.5 ml 
10% SDS solution 100 µl 
10% APS 100 µl 
TEMED 4 µl 
SDS:  sodium dodecyl sulfate, APS: ammonium persulfate, TEMED: N,N,Nʹ,Nʹ-tetramethy-ethane-
1,2-diamine 
 
 
Table 5: Composition of the stacking gel 
INGREDIENTS AMOUNT FOR 1 GEL 
Distilled water 3.4 ml 
30% acrylamide 0.8 ml 
1,0 M Tris, pH 6.8 0.6 ml 
10% SDS solution 50 µl 
10% APS 50 µl 
TEMED 5 µl 
SDS:  sodium dodecyl sulfate, APS: ammonium persulfate, TEMED: N,N,Nʹ,Nʹ-tetramethy-ethane-
1,2-diamine 
 
Table 6: Composition of 10× running buffer 
INGREDIENTS AMOUNT per 1 l 
Tris 30 g 
Glycine 144 g 
10% SDS solution 100 ml 
SDS: sodium dodecyl sulfate 
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2.2.5. Protein blotting 
 
A western blot allows detection of specific proteins in protein mixtures using specific 
antibodies for recognition. For antibody interaction the proteins have to be transferred 
from the polyacrylamide gel to a 0.25 nitrocellulose membrane. For protein transfer was 
used an electric field of 90 V for a duration of 90 min. The procedure was performed in 
blotting buffer (Table 7). 
 
Table 7: Composition of the blotting buffer 
INGREDIENTS CONCENTRATION 
Methanol 20% 
Tris 20 mM 
Glycine 150 mM 
 
The membranes were then washed 2×5 min while shaking on a Roto-Shake Genie 
(Table 8). 
 
Table 8: Composition of the washing buffer  
INGREDIENTS AMOUNT 
10× Dulbecco’s PBS  100 ml 
Tween 20 1 ml  
Distilled water filled up to 1 l 
PBS: phosphate buffered saline, PBST: PBS/Tween 20 
 
 
2.2.6. Protein visualisation 
 
At room temperature, membranes were blocked while shaking in blocking buffer for 1 h 
(Table 9) followed by incubation with the appropriate primary antibodies during 
shaking on a platform shaker at 4 °C overnight. The membranes were washed 3×10 min 
with washing buffer and then incubated with a horse-radish peroxidase (HRPO)-linked 
secondary antibody for 2 h at room temperature followed by 3×10 min washing. The 
concentrations of the primary and secondary antibodies are presented in Table 10. 
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Specific bands were detected by using the Super Signal® West Pico Luminol/Enhancer 
Solution and the Super Signal® West Pico Stable Peroxide Solution. When the signal 
was too weak or not detectable, the ECL Plus Western Blotting Detection Reagents A 
and B were used.  
 
Table 9: Composition of the blocking buffer 
INGREDIENTS CONCENTRATIONS 
PBST Table 8 
Nonfat dry milk 5 % 
PBST: phosphate buffered saline/Tween 20 
 
Table 10: Primary antibodies used in this study 
ANTIBODY DILUTION 
DILUTED 
 IN 
SOURCE 
DILUTION 
Secondary 
antibody  
CATALOGUE 
# 
COMPANY 
Phospho-Akt 1:1000 BSA rabbit 1:2000 9271 Cell Signaling 
Akt 1:1000 BSA rabbit 1:5000 9272 Cell Signaling 
Phospho-AMPKα 1:667 BSA rabbit 1:2000 2535 Cell Signaling 
AMPKα 1:1000 BSA rabbit 1:2000 2532 Cell Signaling 
Phospho- 
β-Catenin 1:500 BSA rabbit 1:1000 9561 Cell Signaling 
β-Catenin 1:1000 BSA rabbit 1:2000 9562 Cell Signaling 
Phospho-GSK3β 1:1000 BSA rabbit 1:2000 9336 Cell Signaling 
GSK3β 1:2000 BSA rabbit 1:2000 9315 Cell Signaling 
MEK1/2 1:1000 BSA rabbit 1:5000 9122 Cell Signaling 
Phospho-p38 1:500 BSA rabbit 1:5000 9211 Cell Signaling 
p38 1:1000 BSA rabbit 1:5000 9212 Cell Signaling 
Phospho-p44/42 1:500 Milk* mouse 1:1000 9106 Cell Signaling 
p44/42 1:1000 BSA rabbit 1:5000 9102 Cell Signaling 
p53 1:2000 BSA rabbit 1:2000 2527 Cell Signaling 
Cleaved PARP 1:1000 Milk* rabbit 1:2000 9545 Cell Signaling 
PARP 1:1000 Milk* rabbit 1:2000 9542 Cell Signaling 
Phospho-SAPK/JNK 1:500 BSA rabbit 1:1000 9251 Cell Signaling 
SAPK/JNK 1:1000 BSA rabbit 1:4000 9252 Cell Signaling 
*Milk = blocking buffer; BSA: bovine serum albumin, AMPKα: adenosine monophosphate-
activated protein kinase α, GSK3β: glycogen synthase kinase 3β, MEK1/2: mitogen-activated 
protein/extracellular signal-related kinase kinases 1/2, PARP: poly-ADP-ribose polymerase, SAPK: 
stress-activated protein kinase, JNK: c-Jun-NH2-terminal kinase. 
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The luminescence of the HRPO product was detected with Kodak Scientific Imaging 
Film or the more sensitive Hyperfilm™ ECL High Performance chemiluminescence 
film. 
The membranes were rinsed with washing buffer (1×10 min) before stripping in a water 
bath of 60 °C for 10 min. For this procedure the membranes were put into a Falcon tube 
with stripping buffer (Table 11). This procedure allows detection of the phosphorylated 
form and thereafter of the total amount of the appropriate protein with one membrane, 
using the described instructions. 
 
Table 11: Composition of 100 ml of stripping buffer 
INGREDIENTS VOLUME 
Double-distilled water 91.7 ml 
10% SDS solution 2 ml 
1.0 M Tris pH 6.8 6.25 ml 
β-mercaptoethanol 0.7 ml 
SDS: sodium dodecyl sulfate 
 
 
2.2.7. RNA isolation 
 
Isolation of RNA from lung tissue was performed according to the manufacturer’s 
instructions provided with RNeasy Protect Mini Kit containing amongst others the 
buffers RLT, RW1, and RPE. 
The RNA isolation and RNA handling until cDNA synthesis were performed under cold 
conditions to prevent RNA degradation. For cooling tissue and/or the centrifuge and 
collection tubes was used liquid nitrogen. 
A lysis buffer containing 20 µl of 2 M DTT per 1 ml RLT buffer was prepared before 
RNA isolation. Analogous to the protein isolation, frozen lung tissue was crushed into 
powder under liquid nitrogen with a mortar and pestle. The lysis buffer (600 µl) was 
added before a 2 min centrifugation in a cooled 2 ml centrifuge tube followed. 
Accordant with the homogenisation of the tissue for the protein analysis, the 
homogenisation was performed with a needle and syringe. The lysate was centrifuged 
for 3 min before the supernatant was transferred to a new centrifuge tube. At the rate of 
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1:1 ethanol (70%) was added. This was mixed by pipetting. The mixture was transferred 
into a combination of RNeasy spin column and collection tube before 15 sec of 
centrifugation (8000 × g). The flow-through was discarded. With 700 µl of RW1 buffer 
it was performed an anew centrifugation for 15 sec at 8000 × g. After discarding the 
flow-through the RNeasy spin column was washed two times with 500 µl of buffer 
RPE. This was performed by one 15 sec and one 2 min centrifugation at 8000 × g. 
Adding 50 µl of RNA free water followed by 1 min centrifugation at 8000 × g led to 
elution of the RNA.  
 
 
2.2.8. Measuring RNA concentration 
 
The concentration and quality of the obtained RNA was determined by measuring the 
optical density of the obtained solutions with a Nanodrop® spectrophotometer. The 
leachate (10 µl) was mixed with 490 µl of 7.0 pH Tris-Cl. The absorbance of the diluted 
sample was measured at 260 nm. The amount of RNA was calculated by using the 
formula C=A260 × 44 µg/ml × 50 where C is the concentration, A260 is the measured 
absorbance, 44 µg/ml is an absolute term describing the correlation of absorbance to the 
concentration of RNA (1 unit absorbance corresponds to 44 µg RNA per ml), and 50 is 
the dilution factor. By multiplication with the volume of the elution the total amount of 
RNA was calculated. 
 
 
2.2.9. cDNA synthesis 
 
Reverse transcriptase is a RNA-dependent DNA polymerase that transcribes the mRNA 
of the obtained solutions into complementary DNA (cDNA). Total RNA (5 µg) was 
combined with 1 µl of random hexamers, 1 µl of dNTP mix and autoclaved water up to 
10 µl total volume. The mixture was incubated at 65 °C for 5 min, chilled on ice for 1 
min, and 10 µl of cDNA Synthesis Mix (Table 12) was added. After gentle mix and 
brief centrifugation these mixtures were incubated at 25 °C for 10 min followed by an 
incubation of 50 min at 50 °C. With a temperature increase to 85 °C for 5 min the 
reactions were stopped by inactivating the reverse transcriptase. The mixtures were put 
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on ice immediately before 1 µl of E. coli RNase H was added. The cDNA was 
generated after a further incubation at 37 °C for 20 min. 
 
Table 12: cDNA Synthesis Mix 
REAGENTS VOLUME 
10× RT buffer 2 µl 
25 mM MgCl2 4 µl 
0.1 M DTT 2 µl 
RNaseOUT™ 1 µl 
SuperScript™ III RT 1 µl 
RT: reverse transcriptase, DTT: dithiothreitol 
 
 
2.2.10. Real-time polymerase chain reaction 
 
Quantitative real-time PCR (qPCR) is used to amplify and quantify a specific DNA 
molecule, where SYBR Green I can be used as a detection system, as SYBR Green I is 
a double-stranded DNA intercalating dye that fluoresces once bound to double-stranded 
DNA. The amount of bound dye correlates with the amount of target amplicon 
generated. 
The reactions were performed according with the manufacturer’s instructions provided 
the Platinum® SYBR® Green qPCR SuperMix-UDG kit (Table 13). 
 
Table 13: Composition of the real-time polymerase chain reaction 
REAGENTS VOLUME 
Platinum® SYBR® Green qPCR 
SuperMix-UDG 
13 µl 
50 mM MgCl2 1 µl 
10 µM forward primer 0.5 µl 
10 µM reverse primer 0.5 µl 
cDNA template 2 µl 
autoclaved water 8 µl 
UDG: uracil-DNA glycosylase 
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The polymerase chain reaction was run with following settings: 2 min with 50 °C for 
UDG incubation, 2 min with 95 °C for the denaturation followed by 40 cycles of 15 s 
with 95 °C for denaturation of the double stranded DNA and 30 s with 60 °C for primer 
annealing and production of complementary DNA strands. The fluorescence intensity 
was measured at the end of the elongation phase. Hypoxanthine 
phosphoribosyltransferase (HPRT) is a so-called housekeeping gene - ubiquitously and 
constitutively-activate gene in mammals - and was used as internal control. For the 
comparability between the measurements it was used the ∆∆Ct method 
(∆∆Ct=∆Ct(treated)-∆Ct(control)). The primers employed are listed in Table 14. 
 
Table 14: Primer sequences 
Gene Accesion  Sequences (5ʹ → 3ʹ) Length Applicon
for CGGTCACACGAACTCAGTCA 20 bp 
APAF1 NM_023979 
rev ACTGCCAAATGGTCGTAGGG 20 bp 
348 bp 
for AGTAGGACTTCGGGGTCTCC 20 bp 
CDKN1A NM_080782 
rev AATGTCAAGGCTCTGGACGG 20 bp 
121 bp 
for CCGCAGAGCAGAAGATCGAA 20 bp 
GADD45A NM_024127 
rev AGTTATGGTGCGCTGACTCC 20 bp 
89 bp 
for GCTTGATTTGTCAAGCGCCA 20 bp 
RBBP7 NM_031816 
rev ACAGTACGCAACAGCTCACT 20 bp 
115 bp 
for AGGCTCCGTGTACTGTGTTG 20 bp 
RGD1561176 NM_001029910
rev CCTGGCACTGTACGGCTAAA 20 bp 
320 bp 
for: forward primer, rev: reverse primer, bp: base pairs 
 
To exclude DNA contamination there was performed a control experiment of the PCR 
without reverse polymerase. If there was DNA detected the sample was contaminated. 
Contaminated samples were discarded. 
 
 
2.2.11. Cryosections - immunohistochemistry 
 
Immunohistochemistry is a method to detect and localise antigens in tissue sections. It 
is based on antibody-antigen interaction and on fluorescence, using a primary antibody 
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against the target antigen. A secondary antibody against the primary antibody is labelled 
with a fluorescent dye that can be examined by microscopy. 
Lung tissue was sectioned with a cryostat. The 6 µm-thick sections were placed on a 
silanised slide. These slides were washed in PBS for 5 min. To make the sections 
permeable sections were put in permeabilisation buffer for 10 min at 4 °C. The 
permeabilisation buffer was produced by mixing 0.1% Triton X-100 and 0.1% sodium 
citrate in PBS. After permeabilisation the slices were washed out with PBS 3×5 min. 
For creating a hydrophobic cycle around the tissue it was used a PAP pen. The slides 
were incubated in 100 µl 10% BSA/PBS for 1 h at 4 °C. After this incubation the slides 
were washed out with PBS 3×5 min. The primary antibodies (Table 15) were diluted in 
100 µl of 0.1% BSA/PBS. 
 
Table 15: Primary antibodies used for immunohistochemistry 
ANTIBODY DILUTION SOURCE CATALOGUE # COMPANY 
Aquaporin 5 1:1000 rabbit 78486 Abcam, UK 
SP-C 1:1000 rabbit AB3786 Chemicon, USA
p53 1:200 mouse 2524 
Cell Signaling, 
USA 
SP-C: surfactant protein C 
 
Incubation with the primary antibodies was performed for 1 h at 4 °C. Protein 
accumulation of p53 was used for the detection of apoptosis, aquaporin 5 was used as a 
marker for type I pneumocytes, and SP-C (surfactant protein C) as a marker for type II 
pneumocytes. After this incubation time, slides were washed with PBS 3×5 min before 
the incubation with the secondary antibodies. Secondary antibodies were Alexa Fluor 
555 goat anti-rabbit IgG and Alexa Fluor 488 goat anti-mouse IgG. The incubation of 
the secondary antibodies was performed in the dark at 4 °C for 1 h at a dilution of 
1:1000 in 100 µl 0.1% BSA/PBS. Sections were washed 3×5 min in PBS. The nuclei of 
all cells were labelled using DAPI (4',6-diamidino-2-phenyl-indol) that binds to DNA 
and fluoresces blue. At room temperature, the sections were incubated with 100 µl of 
1:100 DAPI/PBS for 7 min in the dark. Then, the sections were washed 3×5 min with 
PBS. After incubation with secondary antibody, respectively with the DAPI the sections 
were covered with VECTASHIELD mounting medium for preserving the fluorescence 
MATERIALS AND METHODS 
32 
 
for the microscopic examination. Images of the save field were taken using three 
different fluorescence channels, to identify nuclei (DAPI), cell types (type I 
pneumocytes [aquaporin 5] and type II pneumocytes [SP-C]), and apoptosis (p53). 
 
 
2.2.12. Statistical analysis 
 
The qRT-PCR results were presented as means ± standard error of mean. The ∆∆Ct 
values obtained from qRT-PCR were analysed in groups with Grubbs test to determine 
and exclude statistical outliers. Statistical outliers are referred in the concerning section. 
The data were then subjected to a two-tailed, one-sample Student’s t-test for comparing 
two groups with each other (high PEEP vs. low PEEP, high PEEP vs. control, and low 
PEEP vs. control). Results were considered statistically significant when p < 0.05. For 
the statistical calculations was used GraphPad Prism 5 (GraphPad Software, USA).  
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3. RESULTS 
 
3.1. Protein expression analysis 
 
3.1.1. The mitogen-activated protein kinases  
 
It is known that different extracellular stimuli like stretch at the cell surface evoke a 
change in the activation state of different MAP kinases. Figure 6 illustrates the 
activation states of different MAP kinases due to the different ventilation strategies, and 
in absence and presence of lung injury. 
There was no evidence for a different abundance of phosphorylated MEK1/2 in the 
different treated rat groups. But the phosphorylation state of the ERK1 and ERK2 in 
injured rat lungs was increased compared to the lungs of non-injured rat lungs 
independent of the used ventilation strategy. Further, there was no difference in the 
abundance of phosphorylated JNK in the three different rat groups. It was noted an 
increase in p38 phosphorylation in lung-injured rats independent of the chosen 
ventilation setting. 
Figure 6: Phosphorylated (p) MAP kinases and total MAP kinases in the lung tissue lysates.  
 
 
3.1.2. PI3K-Akt pathway 
 
The PI3K-Akt pathway is known to be involved in cellular responses due to mechanical 
ventilation. Figure 7 illustrates that the fraction of phosphorylated Akt was highest in 
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the rat group with underlying lung injury and ventilated with high PEEP whereas the 
levels of total Akt were similar. The phosphorylation state of GSK3β was increased in 
that group. The fraction of phosphorylated β-catenin was lower in the rat group with 
lung injury that was ventilated with high PEEP. Furthermore, the phosphorylation state 
of AMPKα was lower in the group with lung injury ventilated with high PEEP. These 
results suggest a lung protective effect of high PEEP ventilation settings because the 
PI3K-Akt pathway is known to be involved in anti-apoptotic mechanisms as described 
in section 1.5.1.3. 
 
Figure 7: Expression at phosphorylation status (p) of PI3K-Akt pathway proteins in the different 
lung tissue lysates. 
 
 
3.1.3. Markers of cell death 
 
Both p53 and PARP were investigated as markers of cell death. Figure 8 illustrates that 
highest degree of cell death occured in the group of rats that was ventilated with low 
PEEP after inducing lung injury. The levels of the cell death markers in the rat group 
that was ventilated with high PEEP after lung injury were similar to the levels in that 
group without lung injury suggesting lung protective effects of high PEEP ventilation 
settings. 
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Figure 8: Cell death markers due to the different treatments of the rats. 
 
 
3.2. Gene expression analysis 
 
The amount of specific mRNA correlates with the activation state of the associated 
gene. Selected p53-inducible genes with known pro-apoptotic gene products were 
investigated in this study: Apaf1, CDKN1a and Gadd45a, as well as the pro-apoptotic 
but p53-independent genes retinoblastoma binding protein Rbbp7 and the rat equivalent 
of the ALG2 interacting protein ALIX - RGD1561176.   
 
Figure 9: The gene expression of APAF1 in the low PEEP ventilated rat group, the open lung 
approach ventilated group and the rat group without lung injury compared with HPRT. * indicates 
statistical significance (p<0.05). 
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Figure 10: The gene expression of CDKN1A in the low PEEP ventilated rat group, the open lung 
approach ventilated group and the rat group without lung injury compared with HPRT. * indicates 
statistical significance (p<0.05). 
 
 
 
Figure 11: The gene expression of GADD45A in the low PEEP ventilated rat group, the open lung 
approach ventilated group and the rat group without lung injury compared with HPRT. * indicates 
statistical significance (p<0.05). 
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Figure 12: The gene expression of RBBP7 in the low PEEP ventilated rat group, the open lung 
approach ventilated group and the rat group without lung injury compared with HPRT* indicates 
statistical significance (p<0.05). 
 
 
 
Figure 13: The gene expression of RGD1561176 in the low PEEP ventilated rat group, the open 
lung approach ventilated group and the rat group without lung injury compared with HPRT. 
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With the Grubbs test were identified as statistical outliers the values of rat 10 for the 
CDKN1a and the GADD45a analyses, and the value of rat 9 for the RGD1561176 
analysis; these samples were excluded before the statistical calculations were done. The 
expression of the investigated genes was highest in the tissue lysates of the rat group 
that was ventilated with low PEEP ventilation approach suggesting a pro-apoptotic 
effect of low PEEP ventilation. Whereas the differences between the low and high 
PEEP ventilated rat groups were not statistically significant for the pro-apoptotic but 
p53-independent genes RBBP7 (Figure 12) and RGD1561176 (Figure 13), there was a 
statistical significance between these groups considering the expression state of the pro-
apoptotic and p53-inducible genes APAF1 (Figure 9), CDKN1a (Figure 10) and 
GADD45a (Figure 11). Furthermore, there were no statistical significant differences in 
apoptotic gene expression between the high PEEP ventilated group and the control 
group. These findings provide an evidence of p53-dependent pro-apoptotic mechanisms 
in low PEEP ventilation settings whereas high PEEP ventilation seems to protect the 
lung leading to an outcome as if there was no lung injury. These findings corroborate 
the results of the protein investigations that also demonstrated a higher rate of apoptosis 
in the low PEEP ventilated lung tissue compared to the high PEEP ventilated group.  
 
 
3.3. Immunohistochemistry   
 
Immunohistochemistry was performed to detect the structures of the lungs that are 
affected the most by cell death in VILI.  
Figure 14 illustrates the results with the type I pneumocyte cell marker aquaporin 5. The 
colocalisation of the apoptosis marker p53 with the type I pneumocyte marker 
suggested apoptosis in type I pneumocytes in low PEEP ventilated rats. 
In Figure 15, staining for the type II pneumocyte marker SP-C is illustrated. The 
staining of the apoptosis marker p53 generally did not colocalise with the SP-C staining, 
suggesting, by comparison with Figure 14, that the p53 accumulation is largely found in 
type I pneumocytes rather than in type II pneumocytes. These findings permit the 
conclusion that the type I pneumocytes are affected more by cell death than the type II 
pneumocytes in low PEEP ventilated rats.   
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Figure 14: Images from sections from rat 1. (A) Staining with DAPI, (B) staining with aquaporin 5, 
(C) staining with p53 antibodies. (D) composite of the three images (A), (B) and (C). The arrows 
indicate the colocalisation of aquaporin 5 and p53 staining. 
 
 
 
 
 
 
Figure 15: Images from sections from rat 1. (A) Staining with DAPI, (B) staining with S-PC, (C) 
staining with p53 antibodies. (D) composite of the three images (A), (B) and (C). The arrows 
indicate the divergence of p53 and SP-C staining (bulky arrows: p53 signal without SP-C signal, 
thin arrows: SP-C signal without p53 signal). 
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4. DISCUSSION 
 
Acute respiratory distress syndrome is the major reason for morbidity and mortality in 
patients treated in intensive care units, although lung protective ventilation strategies -
i.e. high PEEP ventilation strategies - lead to a decrease in mortality rate due to ARDS 
(68, 98, 126). The basis of ARDS is a direct or an indirect pulmonary injury (50). 
Mechanical ventilation is the basis of treatment of patients with ARDS (103). But 
mechanical ventilation may itself lead to further damage of the lung tissue by 
mechanical forces (34, 43, 54, 102, 118). To minimize the risk of VILI lung protective 
ventilatory strategies consisting of a PIP of 40-60 cmH2O, a ratio of the duration of 
inspiration to expiration (I:E) of 1:1 to 2:1, a PEEP of 10-20 cmH2O, a permissive 
hypercapnia, and inspiration of low levels of O2 were developed (90).  
 
The aim of this study was to investigate molecular pathways that could be involved in 
the protection of the lung tissue during the lung protective ventilation strategy using 
high PEEP and low tidal volumes, in contrast to a ventilation strategy using lower PEEP 
in a saline washout ARDS rat model. 
 
For most investigations reported here, the whole lung tissue, not individual cells or cell 
types were investigated. The advantage of this kind of investigation is that the organ 
was treated in a natural manner because the organ was located in situ in the organism. 
All interacting mechanisms - direct lung reactions as well as systemic retroactions on 
the lung due to mechanical ventilation - were involved. The handicap of this method is 
that it was not possible to assign the observed reactions to specific cells or cell types. 
The immunohistochemical investigations attempted to fill this gap. 
 
According to the pressure-volume curve illustrated in Figure 2 ventilation settings must 
be adapted to the pressure-volume curve as pictured in Figure 16 to prevent VILI by 
volutrauma or atelectrauma.  
As described in the introduction, volutrauma and atelectrauma are the most important 
determinants of VILI (54). Volutrauma is evoked by application of high end-inspiratory 
volumes (43). Atelectrauma is induced by cyclic opening and collapse of the alveoli 
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(16, 67). In the “open lung” ventilation strategy both of them are prevented because the 
pressure-volume curve is approximated to the scheme in Figure 16.  
 
 
 
Figure 16: Approximation to the pressure-volume curve without induction of traumata leading to 
VILI. 2. Modified from: (102). 
 
 
Barotrauma seems to be largely unimportant for the development of VILI (54, 102). The 
result of using this kind of ventilation strategy should be lung protective ventilation.  
 
The MAP kinases can be activated by mitogens such as TGF-β and bone morphogenetic 
proteins, or due to mechanical stimuli. Two of these MAP kinases are MEK1 and 
MEK2. These kinases are known to be activated due to TGF-β binding to the epidermal 
growth factor receptor (121). Phosphorylation of MEK1/2 usually leads to ERK1/2 
activation. Western blot results revealed an equal phosphorylation state of MEK1/2 in 
all rat groups independent of induction of lung injury and independent of the ventilation 
strategy (Figure 6). Whereas, with western blots it was demonstrated that the 
phosphorylation state of the ERKs was higher in the rat lungs with induced lung injury, 
but there was no difference between the two ventilation strategies (Figure 6). It is 
known that ERK1/2 can be activated via EGF receptors due to mechanical stimuli, such 
as postulated for VILI (22, 31). There are also findings that suggest a cell damaging 
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effect of MEK1/2-mediated ERK1/2 activation (55, 101). The western blot analyses do 
not allow a conclusion as to the cell origin.  
Although the MEK1/2 activation state did not reveal a difference in the rat groups, the 
ERK phosphorylation state was equal in the lung injured rat groups but independent of 
the ventilation strategy increased to the non-injured rat group suggesting an 
upregulation due to lung injury. It can be speculated that an unknown interacting factor 
that is upregulated due to lung protective ventilation inhibits the ERK activation by 
MEK. Taken together, this would speak for a preponderance of the pro-apoptotic power 
of ERK in the whole lung despite possible protective effects in particular lung cells.  
Another MAP kinase that is known to be activated due to pressure applied in 
mechanical ventilation is JNK (115). In the western blot studies, there was no difference 
in the phosphorylation state of the JNK comparing the absence and presence of lung 
injury or with different ventilation settings (Figure 6). Uhlig et al. compared two 
ventilation settings in the absence of lung injury (115). Comparable to the findings in 
this study, there was no significant difference in the JNK phosphorylation state. 
Furthermore, Abdulnour et al. could not find any differences in phosphorylation of JNK 
comparing a high tidal and a low tidal volume ventilation at all (1). Thus, it seems that 
differences in PEEP settings do not lead to an activation of the JNK as well as the 
absence or presence of ARDS. 
The third MAP kinase investigated was p38, which is known to be activated by 
mechanical stress (1, 115). In the investigations of Uhlig et al. no differences were 
found in phosphorylation of p38 between high and low PIP ventilation (115). These 
findings are comparable with the results of the western blots in this study that did not 
reveal any differences between high and low PEEP ventilation, suggesting that the type 
of ventilation strategy is not relevant for p38 activation. But in the data presented here, 
there was a difference in phosphorylation state comparing injured and uninjured rat 
lungs (Figure 6). The kinase p38 is known to be an important factor in development of 
cell damage and blood-gas barrier dysfunction in VILI (13, 18, 32, 116). 
The MAP kinase western blots suggest an activation of ERK1/2 and an activation of 
p38 in the saline lavaged rat lungs compared with non-injured rat lungs. 
 
Akt is a kinase that can lead, via different steps, to inhibition of apoptosis (45, 83, 108). 
The Akt can prevent VILI due to PI3K activation (83). During high PIP ventilation was 
seen an increase of PI3K activation state (83). 
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Western blot analyses in this study revealed an increased Akt activation state in lung 
tissues of the “open lung” ventilated rats. The phospho-Akt levels in the tissues of rats 
that were not injured were similar to the tissue of the low PEEP ventilated rats. 
Consistent with these findings further western blots demonstrated increased 
phosphorylation states of GSK3β in the “lung protective” ventilated rat lung tissues 
(Figure 7). Glycogen synthase kinase 3β is a target of Akt. It is known that 
dephosphorylated GSK3β is involved in apoptosis and lung injury (26). Glycogen 
synthase kinase 3β in dephosphorylated state phosphorylates β-catenin. By 
phosphorylation β-catenin is marked for decomposition leading to decreased blood-gas 
barrier function (69, 83). The western blot analyses of β-catenin revealed that the tissue 
of the high PEEP ventilated rat group contained a lower level of phospho-β-catenin than 
the tissue of the other groups (Figure 7). Indirectly, Akt is able to inactivate another pro-
apoptotic protein – the AMPKα (42, 48, 84, 93). The western blot analyses of AMPKα 
revealed a lower level of the AMPKα phosphorylation state in the rat group with lung 
injury and high PEEP ventilation compared with the other groups (Figure 7).  
Figure 17 gives an overview of the found anti-apoptotic mechanisms due to the “open 
lung” ventilation strategy. 
 
  
Figure 17: Summary of the lung protective cellular mechanisms via Akt in the “open lung” 
ventilation strategy. ATP: adenosine triphosphate, ADP: adenosine diphosphate, AMP: adenosine 
monophosphate, P: phosphate. The interrupted lines indicate the consequences of Akt activation. 
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Via p53, AMPKα is able to induce apoptosis (48, 84, 93). Further western blot analyses 
demonstrated that the p53 levels in the lung tissue of rats ventilated with the protective 
strategy were similar to the p53 levels in the tissue of the non-injured rats. In contrast, 
the p53 levels in the lung tissue of the low PEEP ventilated rats were higher than in the 
high PEEP ventilated rats and in the non-injured rats (Figure 8). Another marker of cell 
death is cleaved PARP (71). Western blots revealed - consistent with the findings for 
the p53 levels - the highest fractions of cleaved PARP in the group with the low PEEP 
ventilation strategy (Figure 8).  
Further, the RT-PCR results demonstrated a higher level of expression for genes that are 
involved in pro-apoptotic mechanisms of cells for the low PEEP ventilated rat groups. 
APAF1 (29, 37, 64), CDKN1A (7, 27, 28), and GADD45A (7, 66, 88) are p53-
inducible genes that are known to be involved in pro-apoptotic mechanisms due to 
induction by p53. The RT-PCR results for these genes revealed a higher expression in 
the low PEEP ventilated rat group compared with the “open lung” ventilated group. The 
results for these genes were statistically significant (Figures 9, 10, 11). These findings 
indicate a p53-dependent pathway of converting cell damaging physical stimuli in low 
PEEP ventilation to apoptosis. Further, there were RT-PCR results of the pro-apoptotic 
but p53-independent genes RBBP7 and RGD1561176 that suggest also a p53-
independent apoptosis pathway. Both genes were upregulated in the low PEEP 
ventilated rat group. In contrast to the results of the p53-inducible genes, the results for 
the p53-independent genes were not statistically significant (Figures 12, 13).  
A reason for anti-apoptotic effects in the high PEEP ventilated rat group may be 
prevention of the atelectrauma that could damage the lung due to shear stress. 
Prevention of the atelectrauma leads to activation of cell protective mechanisms leading 
to decreased gene expression of pro-apoptotic genes. In this way it can be explained that 
the PCR results are similar in the high PEEP ventilated rat group and the rat group 
without induced lung injury whereas the low PEEP ventilated rat group where the gene 
expression of the pro-apoptotic genes is not negatively influenced.  
An overview of apoptotic mechanisms is given in Figure 18. 
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Figure 18: Overview of the pro-apoptotic mechanisms in low PEEP ventilation confirmed by my 
investigations. ATP: adenosine triphosphate, ADP: adenosine diphosphate, AMP: adenosine 
monophosphate, P: phosphate. 
 
 
Taken together, these findings suggest that the “open lung” ventilation strategy in rats 
promotes cell survival and lung protection. The study presented here, as well as the 
work of others, reveal that Akt responds to mechanical stimuli, such as those induced by 
mechanical ventilation, in the lung. It is proposed here that Akt drives the 
phosphorylation, and thereby inactivation, of GSK3β. This would be protective, since 
active GSK3β leads to the degradation of β-catenin, which in turn leads to loss of blood-
gas barrier integrity (69, 83), a key feature of pulmonary oedema (38). The ability of 
Akt to promote phosphorylation, and hence, inactivation of GSK3β, would promote the 
stability of β-catenin, and thus, promote blood-gas barrier integrity. Furthermore, Akt 
may lead, via a reduction in the AMP:ATP ratio (42), to less phosphorylation of 
AMPKα (48, 84), leading to inactivation of AMPKα. The apoptosis rate of affected 
cells would then decrease, because AMPKα promotes cell death (48, 84, 93).  
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A further mechanism of lung protection is the lower steady-state expression level of p53 
in the lungs of “open lung” ventilated rats. Increased steady-state levels of p53, as seen 
in low PEEP ventilated lungs, leads - via gene regulation - to increased rates of 
apoptosis in the lungs of the low PEEP ventilated rats. The pro-apoptotic activity of p53 
is related to the increased expression of pro-apoptotic p53-inducible genes, the 
expression of which was increased in the lungs of low PEEP ventilated rats. However, 
the increased expression of pro-apoptotic p53-independent genes was also noted, 
indicating that p53-independent pro apoptotic pathways were also operative in the lungs 
of low PEEP ventilated rats. 
Thus, this study revealed the activation of anti-apoptotic pathways, particularly the 
PI3K-Akt pathway, and inactivation of pro-apoptotic pathways, including p53-
dependent and p53-independent mechanisms of apoptosis. 
 
Since it was established that the most harmful effects occur in the low PEEP ventilated 
rat lungs it was evident to investigate the most affected cells in a most affected lung. 
The immunohistochemical investigations demonstrated that the cell-injurious stimuli 
impacted primarily the type I pneumocytes (Figures 14, 15). These cells are in the “front 
line” in the barrier to the environment, and protect the other lung tissue from harmful 
physical, chemical, and biological stimuli (52, 99). The reason why type I pneumocytes 
are primarily affected is not known, however, reasons may include the vastly increased 
abundance of type I pneumocytes, and the different biological properties and locations 
of type I pneumocytes when compared with type II pneumocytes. The activation of 
ERK1/2 noted in this study may also have bearing on the differences observed in the 
apoptosis of type I pneumocytes versus type II pneumocytes. All injured (i.e. saline 
lavaged) lungs exhibited an increase in the activation state of ERK1/2, as documented 
by increased levels of ERK1/2 phosphorylation. Thus, ERK1/2 activation appears to be 
a general response to injury in saline-lavaged lungs. Activation of ERKs can lead to 
harmful reactions in the cell, mediated by ROS generation (1, 19, 47). However, 
ERK1/2 activation may also serve to prevent apoptosis, as has been described for 
hyperoxic-injury to type II pneumocytes (15). Thus, it may be speculated that ERK1/2-
drived pathways operate differently in type I pneumocytes versus type II pneumocytes, 
which may underlie the differences observed in the apoptosis of type I pneumocytes 
versus type II pneumocytes. However, no data to support this idea are provided in the 
studies reported here.  
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The data presented here make a strong case for the “open lung” ventilation concept as a 
lung protective ventilation strategy in an intensive care setting. Some of the molecular 
pathways that may underlie this protective effect of high PEEP ventilation have been 
revealed, namely, the activation of Akt, which drives anti-apoptotic, and counteracts 
pro-apoptotic pathways operative in the ventilated, injured lung. Subsequent studies 
should address whether inhibition of Akt activation in this background may negate the 
positive effects of Akt activation during high PEEP ventilation of injured lungs, thus 
validating the Akt pathway as the protective pathway induced by high PEEP ventilation.
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5. ABSTRACT 
 
The acute respiratory distress syndrome (ARDS) is the major reason for morbidity and 
mortality in patients treated in intensive care units. Direct or indirect pulmonary injury 
can lead to ARDS. Mechanical ventilation is the basis of treatment of patients with 
ARDS. Mechanical ventilation may induce by itself further damage of the lung tissue. 
To minimise the risk of subsequent ventilator-induced lung injury (VILI), “protective 
ventilation” strategies were developed. The mechanisms of lung protection due to 
protective ventilation settings are largely unknown.  
The molecular mechanisms of lung protection were examined in lung tissue from a 
saline lavage ARDS rat model. Rats were divided into three groups: one without 
induction of lung injury, one with induction of lung injury and low positive end-
expiratory pressure (PEEP) ventilation, and one group with induction of lung injury and 
high PEEP ventilation (“open lung”).  
From these studies Akt has emerged as a candidate mediator of lung protective 
pathways during mechanical ventilation of lungs with an “open lung” concept. Akt 
inhibits the pro-apoptotic factor p53 directly. Further, Akt inactivates AMP-activated 
protein kinase α (AMPKα) and glycogen synthase kinase 3β (GSK3β). The kinase 
AMPKα normally activates p53, and thus, Akt can also inhibit p53 indirectly. Active 
GSK3β leads to a degradation of β-catenin leading to cell membrane instability and 
apoptosis. This route of apoptosis induction is also subverted by Akt.  
That there was a reduced degree of apoptosis under protective “open lung” ventilation 
was indicated by western blot analyses for the apoptosis marker cleaved poly-ADP-
ribose polymerase (PARP), where the amount of cleaved PARP was lowest in the rat 
group ventilated with the “open lung” strategy. These findings were corroborated by 
real-time PCR analyses of the pro-apoptotic p53-inducible genes APAF1, CDKN1A 
and GADD45A, which presented highest expression levels in the low PEEP-ventilated 
rat group, suggesting p53-dependent apoptotic pathways in VILI. Finally, 
immunohistochemical examinations revealed that the type I pneumocytes were more 
affected by apoptosis than type II pneumocytes during mechanical ventilation of the 
lung.  
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6. ZUSAMMENFASSUNG 
 
Das akute respiratorische Distress-Syndrom (ARDS) ist der Hauptgrund für Morbidität 
und Mortalität von auf Intensivstationen behandelten Patienten. ARDS entwickelt sich 
auf dem Boden einer direkten oder indirekten Schädigung der Lunge. Mechanische 
Beatmung stellt die Basistherapie von ARDS-Patienten dar. Maschinenbeatmung kann 
selbst zu weiteren Schädigungen des Lungengewebes führen. Um das Risiko einer 
entsprechenden beatmungsassoziierten Lungenschädigung (VILI) zu minimieren, 
wurden lungenschonende Beatmungsstrategien entwickelt. Wie diese Strategien die 
Lunge schonen, ist größtenteils noch ungeklärt.  
Molekulare Mechanismen, die zur Lungenschonung beitragen, wurden in 
Lungengeweben eines Saline-Lavage ARDS-Rattenmodells untersucht. Die Ratten 
wurden drei Gruppen zugeteilt: bei einer Gruppe wurde kein ARDS verursacht, bei 
einer wurde nach ARDS-Auslösung ein niedriger PEEP zur Beatmung gewählt und 
einer nach ARDS-Provokation eine Beatmung mit hohem PEEP (“open lung“) 
angeboten. Als Dreh- und Angelpunkt anti-apoptotischer Effekte lungenprotektiver 
Beatmung entpuppte sich Akt. Akt hemmt den pro-apoptotischen Faktor p53 direkt. 
Darüberhinaus inaktiviert Akt sowohl die AMP-aktivierte Proteinkinase α (AMPKα) als 
auch die Glycogensynthasekinase 3β (GSK3β). Normalerweise aktiviert AMPKα p53, 
so dass Akt p53 auch indirekt hemmen kann. Aktive GSK3β führt zum Abbau von β-
Catenin, was zur Instabilisierung von Zellmembranen und auch zur Apoptose führt. 
Dieser Apoptoseweg ist also ebenfalls durch Akt blockiert. Dass unter 
lungenprotektiver Beatmung tatsächlich weniger Zellen in die Apoptose gehen, zeigten 
die Western blot-Analysen mit dem Apoptose-Marker poly-ADP-Ribosepolymerase 
(PARP), bei denen der Anteil von gespaltener PARP in der mit der “open lung”-
Strategie beatmeten Rattengruppe am geringsten war. Diese Ergebnisse wurden von 
real-time PCR-Untersuchungen der pro-apoptotischen, p53-induzierbaren Gene APAF1, 
CDKN1A und GADD45A gestützt, die die höchsten Expressionslevel in der mit 
geringem PEEP beatmeten Gruppe zeigten, was einen p53-abhängigen 
Apoptosesignalweg nahelegt. Schließlich wurde mit immunhistochemischen 
Untersuchungen gezeigt, dass die Typ I-Alveolarepithelzellen in höherem Maße als die 
Typ II-Alveolarepithelzellen von Apoptose unter mechanischer Beatmung betroffen 
sind.
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7. ABBREVIATIONS 
 
A 
ADP     adenosine diphosphate 
ALI     acute lung injury 
AMP     adenosine monophosphate 
AMPK    AMP-activated protein kinase 
Apaf1     apoptotic peptidase activating factor 1 
APS     ammonium persulfate 
ARDS     acute respiratory distress syndrome 
ATP     adenosine triphosphate 
 
B 
BAL     bronchoalveolar lavage 
BMP     bone morphogenetic protein 
BSA     bovine serum albumin 
 
C 
cAMP     cyclic adenosine monophosphate 
CDKN1A    cyclin-dependent kinase inhibitor 1a 
cDNA     complementary DNA  
CO2     carbon dioxide 
 
D 
DAG     diacylglycerol 
DAPI     4',6-diamidino-2-phenyl-indol 
D-MEM    Dulbecco’s modification of Eagle’s medium 
DNA     deoxyribonucleic acid 
dNTP     deoxynucleotide triphosphates 
dsDNA    double-stranded DNA 
DTT     dithiothreitol 
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E 
ECM     extracellular matrix 
EDTA     ethylenediaminetetraacetic acid 
EGF     epidermal growth factor 
EGTA     ethylene glycol tetraacetic acid 
ELISA     enzyme-linked immunosorbent assay 
eNOS     endothelial nitric oxide synthases 
ERK     extracellular signal-related kinase 
 
F 
FCS     foetal calf serum 
FGF     fibroblast growth factor 
 
G 
g     gram or centrifugal force 
Gadd     growth arrest and DNA damage 
GSK3β    glycogen synthase kinase 3β 
GTP     guanosine triphosphate 
 
H 
HEPES    4-(2-hydroxyethyl)-1-piperazineethanesulfonic  
     acid 
HGF     hepatocyte growth factor 
HRPO     horseradish peroxidase 
HPRT     hypoxanthine phosphoribosyltransferase 
 
I 
IFNγ     interferon γ 
IL     interleukin 
IP3                                      inositol-1,4,5-trisphosphate  
 
J 
JNK     c-Jun-NH2-terminal kinase 
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K 
KGF     keratinocyte growth factor 
 
L 
l     liters 
LPS     lipopolysaccharide 
 
M 
µ     micro 
m     milli 
MAPK    mitogen-activated protein kinase 
MEK     mitogen-activated protein/extracellular signal- 
     related kinase kinase 
MKK     mitogen-activated protein kinase kinase 
MLC     myosin light chain 
mRNA    messenger ribonucleic acid 
MSOF     multiple-system organ failure 
mTOR     mammalian target of rapamycin 
 
N 
NF-κB     nuclear factor-κB 
NOS     nitric oxide synthase 
 
P 
PARP      poly-ADP-ribose polymerase 
PBS     phosphate-buffered saline 
PBST     PBS + 0.1 % Tween 20 
PCR     polymerase chain reaction 
PCWP     pulmonary capillary wedge pressure 
PDGF     platelet-derived growth factor 
PEEP     positive end-expiratory pressure 
PI3K     phosphoinositide 3-kinase 
PIP     peak inspiratory pressure 
PIP2     phosphatidylinositol-4,5-bisphosphate 
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PKA     protein kinase A 
PKC     protein kinase C 
PLC     phospholipase C 
PPAR     peroxisome proliferator-activated receptor 
PTK     protein tyrosine kinase 
 
R 
Rbbp 7    retinoblastoma binding protein 7 
ROCK     Rho-associated kinase 
ROS     reactive oxygen species 
rpm     revolutions per minute 
 
S 
SAPK     stress-activated protein kinase 
SDS     sodium dodecyl sulfate 
SIRS     systemic inflammatory response syndrome 
SP-C     surfactant protein C 
 
T 
TEMED    tetramethylethylenediamine 
TGFβ     transforming growth factor-β 
TNFα     tumour necrosis factor α 
Tris     tris(hydroxymethyl)aminomethane 
 
U 
UDG      uracil-DNA glycosylase 
 
V 
V     volt 
VILI     ventilator-induced lung injury 
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